Skip to main content

mequitazine (Primalan®)

 

Following non-submission

AWMSG advice

Status: Not endorsed (Statement of Advice)

In the absence of a submission from the holder of the marketing authorisation, mequitazine (Primalan®) cannot be endorsed for use within NHS Wales for the treatment of allergic conditions such as hay fever, perennial rhinitis, urticaria, pruritis of allergic origin and allergic reactions associated with insect bites and stings.

 Statement of Advice (SOA): mequitazine (Primalan) 1346 (PDF, 43Kb)

Medicine details

Medicine name mequitazine (Primalan®)
Formulation 5 mg tablet
Reference number 1346
Indication

Treatment of allergic conditions such as hay fever, perennial rhinitis, urticaria, pruritis of allergic origin and allergic reactions associated with insect bites and stings

Company Pierre Fabre Ltd
BNF chapter Respiratory system
Submission type Non-submission
Status Not endorsed (Statement of Advice)
Date of issue 01/11/2011
Follow AWTTC: